본문 바로가기
KERD
논문KCI 등재

Serum Bisphenol A Concentration in Postmenopausal Women with Osteoporosis

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류정형외과학

초록

Objectives: Bishphenol A (BPA) is a representative endocrine disruptor and is also known as a xenoestrogen. The objective of the present study is to investigate how many patients are exposed to BPA and to analyze the relationships between serum BPA concentration, bone mineral density (BMD) and biochemical bone markers in postmenopausal women with osteoporosis. Methods: Total 51 patients were enrolled for measuring BPA and clinical variables including BMD and bone markers. The relationship between BPA and clinical variables were analyzed by the Pearson's correlation test and the Kruskal-Wallis test. Serum BPA concentration was measured by enzyme linked immunosorbent assay (ELISA). Results: BPA was detected in all samples. The mean BPA concentration was 1.44 ± 0.52 ng/mL. There was no statistically significant correlation between BPA and clinical variables. Conclusion: There was no statistical significance between serum BPA concentration and clinical variables related to bone metabolism. To clarify the effect of BPA on bone metabolism, further large scaled and high risk group investigation may be needed.

Abstract

Objectives: Bishphenol A (BPA) is a representative endocrine disruptor and is also known as a xenoestrogen. The objective of the present study is to investigate how many patients are exposed to BPA and to analyze the relationships between serum BPA concentration, bone mineral density (BMD) and biochemical bone markers in postmenopausal women with osteoporosis. Methods: Total 51 patients were enrolled for measuring BPA and clinical variables including BMD and bone markers. The relationship between BPA and clinical variables were analyzed by the Pearson's correlation test and the Kruskal-Wallis test. Serum BPA concentration was measured by enzyme linked immunosorbent assay (ELISA). Results: BPA was detected in all samples. The mean BPA concentration was 1.44 ± 0.52 ng/mL. There was no statistically significant correlation between BPA and clinical variables. Conclusion: There was no statistical significance between serum BPA concentration and clinical variables related to bone metabolism. To clarify the effect of BPA on bone metabolism, further large scaled and high risk group investigation may be needed.

참고문헌 (29)

  1. Talsness CE, "Components of plastic: experimental studies in animals and relevance for human health", Philos Trans R Soc Lond B Biol Sci, 364, pp.2079~2096 (2009)
  2. Burridge E, "Bisphenol A: product profile", Eur Chem News, 17, pp.14~20 (2003)
  3. Calafat AM, "Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population", Environ Health Perspect, 113, pp.391~395 (2005)
  4. Calafat AM, "Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004", Environ Health Perspect, 116, pp.39~44 (2008)
  5. Wozniak AL, "Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3", B6 pituitary tumor cells, 2005, pp.113, 431~439
  6. Ropero AB, "Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis", Int J Androl, 31, pp.194~200 (2008)
  7. Moriyama K, "Thyroid hormone action is disrupted by bisphenol A as an antagonist", J Clin Endocrinol Metab, 87, pp.5185~5190 (2002)
  8. Newbold RR, "Effects of endocrine disruptors on obesity", Int J Androl, 31, pp.201~208 (2008)
  9. Yang YJ, "Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women", ENVIRONMENTAL RESEARCH, 109(6), pp.797~801 (2009), ACADEMIC PRESS INC ELSEVIER SCIENCE
  10. Lang IA, "Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults", JAMA, 300, pp.1303~1310 (2008)
  11. Li DK, "Urine bisphenol-A (BPA) level in relation to semen quality", Fertil Steril, 95, pp.625~630e1-4 (2011)
  12. Lirani-Galvão AP, "Physical approach for prevention and treatment of osteoporosis", Arq Bras Endocrinol Metabol, 54, pp.171~178 (2010)
  13. ESHRE Capri Workshop Group, "Bone fractures after menopause", Hum Reprod Update, 16, pp.761~773 (2010)
  14. Suzuki N, "Bisphenol A suppresses osteoclastic and osteoblastic activities in the cultured scales of goldfish", Life Sci, 73, pp.2237~2247 (2003)
  15. Seidlová-Wuttke D, "Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone", Toxicology, 205, pp.103~112 (2004)
  16. Haishima Y, "Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins", J Biomed Mater Res, 58, pp.209~215 (2001)
  17. Murakami K, "Accumulation of bisphenol A in hemodialysis patients", Blood Purif, 25, pp.290~294 (2007)
  18. Le HH, "Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons", Toxicol Lett, 176, pp.149~156 (2008)
  19. Nam SH, "Bisphenol A migration from polycarbonate baby bottle with repeated use", Chemosphere, 79, pp.949~952 (2010)
  20. Yokota H, "Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDPglucuronosyltransferase, UGT2B1, in the rat liver", Biochem J, 340(Pt 2), pp.405~409 (1999)
  21. Völkel W, "Metabolism and kinetics of bisphenol a in humans at low doses following oral administration", Chem Res Toxicol, 15, pp.1281~1287 (2002)
  22. Inoue H, "Bisphenol A glucuronidation and absorption in rat intestine", Drug Metab Dispos, 31, pp.140~144 (2003)
  23. Ginsberg G, "Does rapid metabolism ensure negligible risk from bisphenol A?", Environ Health Perspect, 117, pp.1639~1643 (2009)
  24. Hiroi H, "Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia", Endocr J, 51, pp.595~600 (2004)
  25. Sugiura-Ogasawara M, "Exposure to bisphenol A is associated with recurrent miscarriage", Hum Reprod, 20, pp.2325~2329 (2005)
  26. Cobellis L, "Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women", Biomed Chromatogr, 23, pp.1186~1190 (2009)
  27. 변재천, "자궁근종 환자에서 측정한 혈중 bisphenol-A 농도", Obstetrics & Gynecology Science, 53(10), pp.915~920 (2010), 대한산부인과학회
  28. Kandaraki E, "Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS", J Clin Endocrinol Metab, 96, pp.E480~E484 (2011)
  29. Csanády GA, "Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein", Arch Toxicol, 76, pp.299~305 (2002)

관련 논문AI추천

Effects of Di(2-ethylhexyl)phthalate on Bone Metabolism in Ovariectomized Mice조현희, 최정인대한골대사학회 · 대한골대사학회지2019 · 제26권 제3호The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia김경욱, Ki-Choul Kim, Young-Il Kim대한골대사학회 · 대한골대사학회지2022 · 제29권 제3호The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period김기찬, 김동규, 류상형, 박석교, 심영주, 이재현, 정성욱, 정호중대한재활의학회 · Annals of Rehabilitation Medicine2018 · 제42권 제3호The Associations between Bone Mineral Density and Oxidative Stress Biomarkers in Postmenopausal WomenAlireza Ostadrahimi, Azizeh Farshbaf-Khalili, Farzad Najafipour, Mojgan Mirghafourvand, Nafiseh Ghassab-Abdollahi, Sanaz Malekian대한가정의학회 · Korean Journal of Family Medicine2023 · 제44권 제2호Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial박문석, 성기혁, 이경민, 조성희, 한희수대한골대사학회 · 대한골대사학회지2021 · 제28권 제2호Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal WomenAbdullah Elci, Can B Onder, Huseyin Kayadibi, Nurettin Aka, Sacide Atalay대한진단검사의학회 · Annals of Laboratory Medicine2012 · 제32권 제1호

이 간행물의 다른 논문 (11건)